PTCT (PTC Therapeutics Inc) may reap gains as insiders became active recently

Samantha Gray

PTC Therapeutics Inc’s recent filing unveils that its Director Reeve Emma unloaded Company’s shares for reported $1.09 million on Oct 30 ’25. In the deal valued at $69.50 per share,15,666 shares were sold. As a result of this transaction, Reeve Emma now holds 6,666 shares worth roughly $0.45 million.

Then, Reeve Emma bought 15,666 shares, generating $1,088,787 in total proceeds.

Before that, Boulding Mark Elliott sold 3,375 shares. PTC Therapeutics Inc shares valued at $214,091 were divested by the EXEC. VP AND CLO at a price of $63.43 per share. As a result of the transaction, Boulding Mark Elliott now holds 103,901 shares, worth roughly $7.04 million.

Wells Fargo initiated its PTC Therapeutics Inc [PTCT] rating to an Overweight in a research note published on October 20, 2025; the price target was $73. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in mid June with a ‘”a Buy”‘ rating. BofA Securities also remained covering PTCT and has increased its forecast on May 09, 2025 with a “Buy” recommendation from previously “Neutral” rating. Citigroup revised its rating on May 07, 2025. It rated PTCT as “a Neutral” which previously was an “a Sell”.

Price Performance Review of PTCT

On Tuesday, PTC Therapeutics Inc [NASDAQ:PTCT] saw its stock fall -0.31% to $67.72. Over the last five days, the stock has gained 0.34%. PTC Therapeutics Inc shares have risen nearly 69.64% since the year began. Nevertheless, the stocks have risen 50.02% over the past one year. While a 52-week high of $69.88 was reached on 10/30/25, a 52-week low of $35.95 was recorded on 05/06/25.

Levels Of Support And Resistance For PTCT Stock

The 24-hour chart illustrates a support level at 66.35, which if violated will result in even more drops to 64.99. On the upside, there is a resistance level at 68.94. A further resistance level may holdings at 70.17.

How much short interest is there in PTC Therapeutics Inc?

A steep rise in short interest was recorded in PTC Therapeutics Inc stocks on 2025-10-15, growing by 0.52 million shares to a total of 7.82 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 7.29 million shares. There was a rise of 6.7%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.